Breast cancer is the leading cause of cancer death among women worldwide. While triple-negative breast cancer is less common among various sub-types of breast cancer, it tends to affect younger women and is more aggressive, having a higher rate of early recurrence and mortality compared to other sub-types. We know about the association between triple-negative breast cancer and BRCA mutations, which are highly prevalent in founding populations of European origin, but the true prevalence of these mutations in Latin American populations is unknown. There is also very little information about the demographic and epidemiological aspects of triple-negative breast cancer in Latin America, which we will try to summarise in this article. In addition, we will try to provide a brief introduction to the most common recommendations for treating this histological class in Latin America.
Caglevic, C., Anabalón, J., Soza, C., Milla, E., Gaete, F., Carrasco, A. M., … Mahave, M. (2019). Triple-negative breast cancer: The reality in Chile and in Latin America. Ecancermedicalscience, 13. https://doi.org/10.3332/ecancer.2019.893